DOUGLAS HOY: Open Payments
NPI 1437139755 · BELLEVUE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 32 payments from 14 companies in 2025. Trend: 2023 $340 · 2024 $536 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $142 |
| Lilly USA, LLC | 4 | $70 |
| PFIZER INC. | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Corium, LLC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
Products named: LINZESS, UBRELVY, XIFAXAN, Azstarys, AIRSUPRA, NURTEC ODT, MOUNJARO, INSPIRE.
Industry payments across OH — which companies pay providers there.
